Advertisement

NEOG

Neogen Corporation

Healthcare · USD

Set alert

Price alert · NEOG

All alert types
11.82 USD -0.44 -3.59%
As of Oct 30, 2026 Extended hours 11.82 0.00%
Bid
11.81 × 2
Ask
11.82 × 2
11.63 Day range 12.24
5.41 52-week range 13.98
YTD
+69.10%
1 year
+97.00%
Open
12.15
Prev close
12.26
Mkt cap
2.58B
Vol
1.95M
Avg vol
3.35M
EPS
-0.26
P/E
0.00
Div yield
0.00%
More statistics
Low
11.63
High
12.24
Forward P/E
26.03
Beta
1.79
Short ratio
2.26
Inst. own
111.21%
Dividend
0.00
Ex-div date
Earnings
Jan 14, 2027
50-d avg
12.23
200-d avg
10.41
1y target
14.00

5D chart

Chart tools
Interval
NEOG five-day price chart11.812.112.312.612.8Oct 23Oct 26Oct 27Oct 28Oct 29

Key statistics

Market cap
2.56B
Enterprise value
3.28B
Trailing P/E
0.00
Forward P/E
26.03
PEG ratio
0.66
Price / sales
2.89
Price / book
1.23
EPS (TTM)
-0.26
Beta
1.79
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-6.35%
Revenue (TTM)
884.00M
Revenue growth
6.50%
Free cash flow
38.94M
Total cash
172.00M
Total debt
774.30M
Return on equity
-2.67%
Shares outstanding
218.31M
Short % of float
7.30%
50-day average
12.23
200-day average
10.41

Analyst view

Consensus: buy

Buy
Price target (mean) 14.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Jan 14, 2027

Expected Jan 14, 2027. Consensus EPS estimate 0.06333.

Earnings history

Financials — quick view

All financials
NEOG Revenue — quarterly 222.80M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
NEOG Net income — quarterly -11.90M
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026
NEOG EPS — quarterly -0.05
2023-Q2 20222023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20232024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20242025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20252026-Q3 20262026-Q4 20262027-Q1 2026

Earnings

NEOG recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 14, 2027Nov 30, 20260.07———
Oct 6, 2026Aug 31, 20260.053330.08+0.03+50.01%
Jul 30, 2026May 31, 20260.056670.09+0.03+58.81%
Apr 9, 2026Feb 28, 20260.040.09+0.05+125.00%
Jan 8, 2026Nov 30, 20250.070.10+0.03+42.86%
Oct 9, 2025Aug 31, 2025-0.0740.04+0.11+154.05%

Upgrades / downgrades

NEOG analyst upgrades and downgrades
DateFirmActionFromTo
Sep 30, 2026GuggenheimmainBuyBuy
Aug 26, 2026Piper SandlerupNeutralOverweight
Aug 3, 2026Piper SandlerreitNeutralNeutral
Jan 12, 2026Piper SandlerreitNeutralNeutral
Jan 9, 2026GuggenheimmainBuyBuy
Dec 10, 2025CJS SecuritiesupMarket PerformMarket Outperform

About Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis. The company has a strategic collaboration with Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
neogen.com

News

Your note

Sign in to keep a note on NEOG — it syncs with the Stock Master app.

Insider holders

NEOG insider holders
InsiderRelationLatest transactionDateShares held
ADENT JOHN EDWARDFormerConversion of Exercise of derivative securityOct 26, 2025363,081
BOEHM WILLIAM TDirectorConversion of Exercise of derivative securityOct 26, 202547,913
BOREL JAMES C.DirectorConversion of Exercise of derivative securityOct 26, 202594,570
JONES DOUGLAS EDWARDFormerConversion of Exercise of derivative securityOct 26, 2025100,881
NAEMURA DAVID HARTMANFormerConversion of Exercise of derivative securityNov 30, 202590,388
NASSIF MIKHEALChief Executive OfficerStock Award(Grant)Aug 13, 2026141,631

Institution ownership

NEOG institution ownership
Holder% heldSharesValueReported
Blackrock Inc.15.31%33,431,015391.64MJun 29, 2026
Neuberger Berman Group, LLC7.59%16,570,795194.13MJun 29, 2026
Vanguard Portfolio Management LLC5.97%13,038,732152.75MJun 29, 2026
Dimensional Fund Advisors LP4.50%9,828,174115.14MJun 29, 2026
Vanguard Capital Management LLC4.42%9,655,248113.11MJun 29, 2026
SG Americas Securities, LLC4.28%9,352,065109.56MJun 29, 2026

Fund ownership

NEOG fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF5.95%12,983,088152.10MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%6,928,35881.17MJun 29, 2026
NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund3.13%6,842,46480.16MSep 29, 2026
iShares Trust-iShares Russell 2000 ETF2.63%5,738,52667.23MSep 29, 2026
BARON INVESTMENT Fd.S TRT -Baron Small Cap Fd.2.29%5,000,00058.58MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.28%4,987,15858.42MJun 29, 2026
Advertisement